According to recent study results, hyperglycaemia has been recognised as an “independent risk factor for mortality” for people with COVID-19.
Hyperglycaemia has been found to pose nearly double the risk of mortality to people with COVID-19 who do not have diabetes, despite diabetes being distinguished as a risk factor for individuals with COVID-19.
The study suggests that the mortality risk in people with COVID-19 who have been admitted to hospital can be adapted and improved using glucose control.
The research surveyed data from 74,148 people with, and without, pre-existing diabetes who had tested positive for COVID-19 and were admitted to hospital.
Statistics from one or more glucose measurement per individual were assessed to investigate and identify the link between hyperglycaemia and poor outcomes.
A hyperglycaemic measurement during their time in hospital was associated with a higher risk of morality when compared to those who had glucose measurements that were within the “normal range”.
The risk of mortality for people with pre-existing diabetes increased by 10.1% when they had a glucose measurement classified as hyperglycaemic. Whereas risk for individuals without pre-existing diabetes increased by 18.4%, the study said.
Nevertheless, COVID-19 mortality is still higher in people with diabetes, whether hyperglycaemia was detected or not.